Product Name :
NVP-DPP728
CAS No.:
247016-69-9
Purity :
> 99%
Shipping:
Shipped on dry ice.
Storage :
Protect from light.Powder: -80 °C, 2 years; -20 °C, 1 year.In solvent: -80 °C, 6 months; -20 °C, 1 month (protect from light).
SMILES:
Product Description :
NVP-DPP728 is a potent, reversible and nitrile-dependent dipeptidyl peptidase IV (DPP-IV) inhibitor. NVP-DPP728 can inhibit human DPP-IV amidolytic activity with a Ki of 11 nM. NVP-DPP728 inhibits degradation of glucagon-like peptide-1 (GLP-1) and thereby potentiates insulin release in response to glucose intake. NVP-DPP728 can be used for researching diabetes.
Formula:
C15H18N6O
Molecular Weight :
298.34
Synonyms:
Additional Information:
|CAS No. 247016-69-9 ; |Formula C15H18N6O ; |Molecular Weight 298.{{Mezigdomide} MedChemExpress|{Mezigdomide} E1/E2/E3 Enzyme|{Mezigdomide} Technical Information|{Mezigdomide} Description|{Mezigdomide} manufacturer|{Mezigdomide} Autophagy} 34 ; |Target DPP-IV ; |Product Description NVP-DPP728 is a potent, reversible and nitrile-dependent dipeptidyl peptidase IV (DPP-IV) inhibitor.{{Pembrolizumab} medchemexpress|{Pembrolizumab} PD-1/PD-L1|{Pembrolizumab} Purity & Documentation|{Pembrolizumab} References|{Pembrolizumab} custom synthesis|{Pembrolizumab} Autophagy} NVP-DPP728 can inhibit human DPP-IV amidolytic activity with a Ki of 11 nM.PMID:23557924 NVP-DPP728 inhibits degradation of glucagon-like peptide-1 (GLP-1) and thereby potentiates insulin release in response to glucose intake. NVP-DPP728 can be used for researching diabetes. ; |Format Solid ; |Purity > 99% ; |Shipping Shipped on dry ice. ; |Storage Protect from light.Powder: -80 °C, 2 years; -20 °C, 1 year.In solvent: -80 °C, 6 months; -20 °C, 1 month (protect from light). ; |Solubility Overview Soluble in DMSO